| The blood-brain barrier in health and chronic neurodegenerative disorders BV Zlokovic Neuron 57 (2), 178-201, 2008 | 3845 | 2008 |
| Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders BV Zlokovic Nature Reviews Neuroscience 12 (12), 723-738, 2011 | 3099 | 2011 |
| Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders MD Sweeney, AP Sagare, BV Zlokovic Nature Reviews Neurology 14 (3), 133-150, 2018 | 2520 | 2018 |
| Blood-brain barrier breakdown in the aging human hippocampus A Montagne, SR Barnes, MD Sweeney, MR Halliday, AP Sagare, Z Zhao, ... Neuron 85 (2), 296-302, 2015 | 2009 | 2015 |
| RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain R Deane, S Du Yan, RK Submamaryan, B LaRue, S Jovanovic, E Hogg, ... Nature medicine 9 (7), 907-913, 2003 | 1789 | 2003 |
| Clearance of Alzheimer’s amyloid-β1-40 peptide from brain by LDL receptor–related protein-1 at the blood-brain barrier M Shibata, S Yamada, SR Kumar, M Calero, J Bading, B Frangione, ... The Journal of clinical investigation 106 (12), 1489-1499, 2000 | 1774 | 2000 |
| Blood-brain barrier: from physiology to disease and back MD Sweeney, Z Zhao, A Montagne, AR Nelson, BV Zlokovic Physiological reviews, 2018 | 1749 | 2018 |
| Clearance systems in the brain—implications for Alzheimer disease JM Tarasoff-Conway, RO Carare, RS Osorio, L Glodzik, T Butler, ... Nature reviews neurology 11 (8), 457-470, 2015 | 1593 | 2015 |
| Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging RD Bell, EA Winkler, AP Sagare, I Singh, B LaRue, R Deane, BV Zlokovic Neuron 68 (3), 409-427, 2010 | 1589 | 2010 |
| Establishment and dysfunction of the blood-brain barrier Z Zhao, AR Nelson, C Betsholtz, BV Zlokovic Cell 163 (5), 1064-1078, 2015 | 1530 | 2015 |
| Apolipoprotein E controls cerebrovascular integrity via cyclophilin A RD Bell, EA Winkler, I Singh, AP Sagare, R Deane, Z Wu, DM Holtzman, ... Nature 485 (7399), 512-516, 2012 | 1353 | 2012 |
| Blood–brain barrier breakdown is an early biomarker of human cognitive dysfunction DA Nation, MD Sweeney, A Montagne, AP Sagare, LM D’Orazio, ... Nature medicine 25 (2), 270-276, 2019 | 1321 | 2019 |
| Neurovascular mechanisms of Alzheimer's neurodegeneration BV Zlokovic Trends in neurosciences 28 (4), 202-208, 2005 | 1226 | 2005 |
| Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease K Kisler, AR Nelson, A Montagne, BV Zlokovic Nature Reviews Neuroscience 18 (7), 419-434, 2017 | 1147 | 2017 |
| Central nervous system pericytes in health and disease EA Winkler, RD Bell, BV Zlokovic Nature neuroscience 14 (11), 1398-1405, 2011 | 1124 | 2011 |
| Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease RD Bell, BV Zlokovic Acta neuropathologica 118, 103-113, 2009 | 1100 | 2009 |
| Pericytes of the neurovascular unit: key functions and signaling pathways MD Sweeney, S Ayyadurai, BV Zlokovic Nature neuroscience 19 (6), 771-783, 2016 | 1073 | 2016 |
| LRP/amyloid β-peptide interaction mediates differential brain efflux of Aβ isoforms R Deane, Z Wu, A Sagare, J Davis, S Du Yan, K Hamm, F Xu, M Parisi, ... Neuron 43 (3), 333-344, 2004 | 1019 | 2004 |
| APOE4 leads to blood–brain barrier dysfunction predicting cognitive decline A Montagne, DA Nation, AP Sagare, G Barisano, MD Sweeney, ... Nature 581 (7806), 71-76, 2020 | 998 | 2020 |
| The cytoprotective protein C pathway LO Mosnier, BV Zlokovic, JH Griffin Blood 109 (8), 3161-3172, 2007 | 971 | 2007 |
